Evaluating the effects of Ashwagandha on stress levels
Official title: The Effectiveness of a Proprietary Ashwagandha Extract on Stress Reduction: A Three-Arm Randomized, Double-Blinded, Placebo Controlled Clinical Trial
Run by Nutraceuticals Research Institute · NCT06793891 · Data updated 2026-11-12
This study is testing if two different types of ashwagandha can help people lower their stress levels compared to a placebo over 60 days.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 30 Years to 59 Years |
| Sex | Women only |
| Enrollment | 60 (estimated) |
| Sponsor | Nutraceuticals Research Institute Academic / other |
| Locations | 1 site (Huntsville, Alabama) |
| Status | Recruiting |
| Started | October 21, 2024 |
| Main results expected | March 31, 2025 |
| Study ends | April 30, 2025 |
| Registry record updated | January 27, 2025 |
| Trial ID | NCT06793891 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 30 to 59 who self-report high stress levels and meet specific health criteria.
✕Probably not a fit
Patients who are pregnant, breastfeeding, or have a history of substance abuse may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to assess the efficacy of two proprietary ashwagandha extracts in reducing stress levels compared to a placebo. Participants will take either the ashwagandha root extract, a combination of root and leaf extracts, or a placebo daily for 60 days. The study will measure outcomes related to stress, sleep, energy, and cognition to determine the effectiveness of the interventions.
Why it matters
Potential benefit: If successful, this study could provide a natural approach to managing stress and improving overall well-being.
How similar studies have gone: While there is existing research on ashwagandha, this specific approach to evaluating its effects on stress levels is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Provision of signed and dated informed consent form * Stated willingness and demonstrated ability to comply with all study procedures, as well as availability for the duration of the study * Self reported high stress * Baseline score of above-average stress levels on the NRI-SS * Biological sex of woman; gender identification of female * Aged 30 to 59, inclusive * Good general health as evidenced by medical history and screening * For females of reproductive potential: use of highly effective contraception for at least 1 month prior to screening and agreement to use such a method during study participation and for an additional month after the end of the study * Agreement to adhere to Lifestyle Considerations throughout study duration Exclusion Criteria: * Pregnancy, trying to conceive, or breastfeeding * Currently smokes or vapes (i.e., tobacco, flavored items, marijuana, etc.) or has in the past year * Consumes \> 8 alcoholic beverages in an average week * Is a primary caretaker for a child younger than 18 months of age * Currently consumes an ashwagandha supplement or has consumed one regularly (defined as 1x week or more often) within the past 24 months * Consumes any stress aid, medication, diet, or supplement intended to improve stress in any way * Current or recent (within 60 days) history of taking thyroid medications, hypertensive drugs, CNS depressants, diabetic medications, benzodiazepines, or immunosuppressants * Any liver or kidney disorder * Known allergic reactions to any components of the intervention * Positive COVID-19 test within 30 days of the study period * Recent dramatic weight changes (10% change in body weight in the last 6 months) * Introducing a new investigational drug or other intervention within 60 days before the start of the study * Introducing a new lifestyle stress-reduction aid (i.e. physical activity, yoga, etc) within 60 days before the start of the study
Where it's running
-
Nutraceuticals Research Institute
Huntsville, Alabama, United States Recruiting
Study contacts
- Study coordinator: Jessie Hawkins, PhD
- Email: j.hawkins@nutraceuticalsresearch.com
- Phone: 256-203-9010
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Diabetes, Dementia, and Oxidative Stress: A look at Nox2-related markers
This study tests whether oxidative stress linked to Nox2 is related to dementia risk in adults with type 2 diabetes.
-
Opioid-Free vs Opioid-Based Anesthesia for Thyroid Surgery
This study tests whether a non-opioid anesthesia approach can match or improve outcomes for adults undergoing thyroidectomy.
-
Training to reduce oxidative stress in knee OA
A six-week program compares supervised knee-strengthening training with a daily 6,000-step walking plan to see if it improves pain, function, and blood markers of cellular stress in people with knee osteoarthritis.
-
Ashwagandha with resistance training to boost strength and stress markers
This 12-week study tests whether taking ASHWAGANDHA along with regular resistance training helps healthy, trained men see improvements in strength, stress levels, sleep, and cognitive function compared with a placebo.
-
Oxidative Stress and Heart Risk in People with Rheumatoid Arthritis
This study tests whether certain markers of oxidative stress in people with rheumatoid arthritis are linked to subclinical atherosclerosis and arterial stiffness, which could relate to future heart disease risk.
-
NVTIA Ergothioneine for Healthy Aging and Skin Health
This study tests whether taking NVTIA Ergothioneine daily for 12 weeks helps healthy adults age more gracefully and keeps skin looking and feeling better compared with a placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.